Skip to content
★ Sign in to follow
Entero Healthcare Solutions Limited logo

Entero Healthcare Solutions Limited Stock: price and insider trades · India

IN·Mcap ₹72.5BHealth Care

Entero Healthcare Solutions Limited: what insiders have been doing

This page follows insider dealings at Entero Healthcare Solutions Limited as filed with SEBI (PIT + SAST), a company from the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 1 filing came from 1 insider.

The flow runs one way only: 1 sale, from 1 insider, and no purchase. The totals exclude 1 filing filed without an amount.

Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

Compared with its exchange (1,890 companies, median 4 filings), a count of 1 filing is below the norm. Since 2024, the database holds no purchases and 5 sales by insiders of the company.

Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.

Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€82,971
5 ops. · all time

Who traded when

BuySale
ICICI Prudential Mutual Fund1 sale

Analyst consensus: bullish or bearish?

Analysts rate Entero Healthcare Solutions Limited Strong Buy (bullish), based on 5 analysts. Average price target: ₹1,844.40.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 20,293 of 26,911 companies
34.1
score / 100
Value
32
Quality
36
FCF yld0.4%
Earn yld1.8%
EV/EBITDA26.6x
ROE8.3%
Gross mgn9.6%
Net mgn1.8%
Debt/EBITDA2.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹1,665.50
Analyst consensus
5 analysts
Strong buy
₹1,590.00Target ₹1,844.40(+11%)₹2,132.00
Income statement
Revenue₹65.4B
Gross profit₹6.3B10% margin
EBITDA₹2.7B4% margin
Net income₹1.2B1.8% margin
Valuation
PER (trailing)57.9x
PER (forward)29.0x
P/Book4.3x
Beta-0.49
Balance sheet & cash
Market cap₹72.5B
Total debt₹6.8B
Free Cash Flow₹286.6M
Debt / Equity39%
Profitability & ownership
ROE8.3%
ROA4.4%
% insiders64.8%
% institutions20.4%
Last declaration on 29 May 2026
Declarations5 total
  • ▼
    Related company / holdingExecutives
    0SEBI
    1,241,611 shares-MarketSEBI:41418a1d9a829299fc39d0c3b24989f2d1de79ea
  • ▼
    Executives
    3M INR23SEBI
    2,179 shares@ ₹1,321.975762.0% of flowEquity SharesSEBI:8b40785bb3c639a4cf584fb6834544820510d82c
  • ▼
    Executives
    2M INR21SEBI
    1,350 shares@ ₹1,315.0038.0% of flowEquity SharesSEBI:f5529f5874e72a25462a9778a7d8667168edf7b1
  • ▼
    -
    Executives
    2M INR22SEBI
    1,200 shares@ ₹1,282.7175100.0% of flowEquity SharesSEBI:5fd30c828d77701daf5c40ce94fee088944a3e6b
  • ▼
    Executives
    2M INR22SEBI
    1,200 shares@ ₹1,282.7175100.0% of flowEquity SharesSEBI:cee6db910afcd6e708d3b63e48b41231f35377d9

5 of 5 declarations

About Entero Healthcare Solutions Limited

Entero Healthcare Solutions Limited is a company focused on the distribution of pharmaceutical products and medical devices. It primarily operates in the European market, providing innovative healthcare solutions.